SEC Form 4 · accession 0001292445-16-000006
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W Breckon
Director
Period of report
Feb 4, 2016
Accepted (ET)
Feb 5, 2016 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Feb 4, 2016 | S | 1,095 | $38.58 | D | 8,432 | D | |
| Class A Common Stock | Feb 4, 2016 | M | 2,787 | $8.45 | A | 11,219 | D | |
| Class A Common Stock | Feb 4, 2016 | S | 2,366 | $40.70 | D | 8,853 | D | |
| Class A Common Stock | Feb 4, 2016 | S | 421 | $40.00 | D | 8,432 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F2 | $8.45 | Feb 4, 2016 | M | 2,787 | D | — | Sep 28, 2020 | Class A Common Stock | 2,787 | 9,047 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2015.
- F2The shares subject to this option vest yearly in five equal installments beginning on September 28, 2011, subject to continued service on the Issuer's Board of Directors.